Published research is providing additional evidence of the effectiveness and safety of rapid-acting non-invasive brain stimulation therapy to treat people suffering from bipolar depression.
Read More
In their efforts to understand the beneficial effects of SAINT, an important new fast-acting brain stimulation treatment for refractory major depression, researchers now think they understand why it…
Read More
On September 6, 2022, the U.S. Food and Drug Administration cleared the way for marketing of a rapid-acting brain-stimulation approach for major depressive disorder pioneered by Nolan Williams, M.D…
Read More
